{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:11:49Z","timestamp":1785942709937,"version":"3.56.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574790"],"award-info":[{"award-number":["82574790"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ShanDong Provincial Medical Association","award":["YXH2025YS080"],"award-info":[{"award-number":["YXH2025YS080"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00977-1","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:33:51Z","timestamp":1785940431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025"],"prefix":"10.1186","volume":"14","author":[{"given":"Zezhou","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruirong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0560-2388","authenticated-orcid":false,"given":"Siyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"Supplement 1","key":"977_CR1","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1182\/blood-2025-732","volume":"146","author":"J Kaili Wang","year":"2025","unstructured":"Kaili Wang J, Wang R, Feng K, Dudnyk YJ, Kim JYS, Lim, et al. Silencing of BCL11A by disrupting enhancer-dependent epigenetic insulation. Blood. 2025;146(Supplement 1):732. https:\/\/doi.org\/10.1182\/blood-2025-732.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR2","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.1182\/blood-2025-6090","volume":"146","author":"J Chen","year":"2025","unstructured":"Chen J, Lai Y, Zhai X, Zhao WL, Liu R, Qian X, et al. Rapid, efficient and durable fetal hemoglobin production following CS-101 treatment in transfusion-dependent \u03b2-thalassemia participants: An autologous, ex vivo edited CD34\u2009+\u2009stem cell product using the innovative transformer base editor (tBE). Blood. 2025;146(Supplement 1):6090. https:\/\/doi.org\/10.1182\/blood-2025-6090.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR3","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1182\/blood-2025-4314","volume":"146","author":"H Rabi Hanna","year":"2025","unstructured":"Rabi Hanna H, Frangoul L, Pineiro C, McKinney M, Mapara J, Dalal, et al. CRISPR-Cas12a gene editing of the HBG1\/2 promoters leads to sustained normalization of total hemoglobin and increased fetal hemoglobin in patients with severe sickle cell disease: Updated Results from the RUBY trial. Blood. 2025;146(Supplement 1):4314. https:\/\/doi.org\/10.1182\/blood-2025-4314.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR4","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1182\/blood-2025-2532","volume":"146","author":"A Gupta","year":"2025","unstructured":"Gupta A, Sharma A, Frangoul H, Kanter J, Mapara M, Dalal J, et al. Robust HbF induction and improvement of anemia and hemolysis with base editing in sickle cell disease: Safety and efficacy findings from the ongoing BEACON study. Blood. 2025;146(Supplement 1):2532. https:\/\/doi.org\/10.1182\/blood-2025-2532.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR5","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1182\/blood-2025-2914","volume":"146","author":"GD Luna","year":"2025","unstructured":"Luna GD, Cretin J, Redjoul R, Beckerich F, Habibi A, Hebert N, et al. Evaluating the efficacy and safety of gene therapy in transfusion-dependent \u03b2-thalassemia: A focus on hemolysis improvement and clonal hematopoiesis monitoring. Blood. 2025;146(Supplement 1):2914. https:\/\/doi.org\/10.1182\/blood-2025-2914.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR6","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2025-2533","volume":"146","author":"L Erica Esrick","year":"2025","unstructured":"Erica Esrick L, Lehmann A, Federico H, Daley C, Dansereau S, DeOliveira, et al. Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trial. Blood. 2025;146(Supplement 1):2533. https:\/\/doi.org\/10.1182\/blood-2025-2533.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR7","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1182\/blood-2025-1379","volume":"146","author":"C Li","year":"2025","unstructured":"Li C, Shin H, Bhavanasi D, Liu X, Liu M, Xiang Y, et al. Expansion of human hematopoietic stem cells by inhibiting translation. Blood. 2025;146(Supplement 1):1379. https:\/\/doi.org\/10.1182\/blood-2025-1379.","journal-title":"Blood"},{"key":"977_CR8","doi-asserted-by":"publisher","unstructured":"Ahmed R, Thirumaran M, Ali H, Jehangir D, Rosas J, Alexander Santhi JL, et al. Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): a faers disproportionality study, 2014\u20132025. Blood. 2025;146 (Supplement 1): 7838. https:\/\/doi.org\/10.1182\/blood-2025-7838.","DOI":"10.1182\/blood-2025-7838"},{"issue":"Supplement 1","key":"977_CR9","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1182\/blood-2025-1063","volume":"146","author":"G-H Hwang","year":"2025","unstructured":"Hwang G-H, Peters M, Andresen F, Zeng J, Kathi H, Levesque S\u00e9bastien, et al. Efficient prime editing of human hematopoietic stem cells corrects the recurrent SBDS C.258\u2009+\u20092T\u2009>\u2009C mutation and recovers engraftment potential in shwachman-diamond syndrome. Blood. 2025;146(Supplement 1):1063. https:\/\/doi.org\/10.1182\/blood-2025-1063.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR10","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1182\/blood-2025-2536","volume":"146","author":"G Yaser Heshmati","year":"2025","unstructured":"Yaser Heshmati G, Schiroli L, Tozzi M, Monte N, Beytour A, Wangweerawong, et al. In Vivo correction of the sickle cell disease mutation in hematopoietic stem cells using RNA gene writers. Blood. 2025;146(Supplement 1):2536. https:\/\/doi.org\/10.1182\/blood-2025-2536.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1182\/blood-2025-1065","volume":"146","author":"S Radtke","year":"2025","unstructured":"Radtke S, Thomas J, Choo S, Petty N, Rupert P, Kanestrom G, et al. In Vivo hematopoietic stem cell (HSC) engineering and selection with CD90-targeted multiplexed virus-like particles (MVPs) for HSC gene therapy and cancer immunotherapy. Blood. 2025;146(Supplement 1):1065. https:\/\/doi.org\/10.1182\/blood-2025-1065.","journal-title":"Blood"},{"issue":"Supplement 1","key":"977_CR12","doi-asserted-by":"publisher","first-page":"7835","DOI":"10.1182\/blood-2025-7835","volume":"146","author":"O Sarah Cotteta","year":"2025","unstructured":"Sarah Cotteta O, Banda F, Herbst-Nowrouzi B, McDonald Y, Wang M-G, Alameh, et al. Toward \u2018n of one\u2019 gene therapies: Scalable ex vivo adenine base editing via lipid nanoparticles in a sickle cell disease model. Blood. 2025;146(Supplement 1):7835. https:\/\/doi.org\/10.1182\/blood-2025-7835.","journal-title":"Blood"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00977-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00977-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:33:52Z","timestamp":1785940432000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00977-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["977"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00977-1","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable for this summary.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for this summary.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"86"}}